BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)

An Open-Label Extension Study to Evaluate the Safety and Efficacy of BG9924 When Given in Combination With Methotrexate to Subjects With Rheumatoid Arthritis Who Previously Participated in Study 104RA203

This study is to observe the long-term treatment of BG9924

Extension study for 104RA203 (NCT 00458861)

Inclusion Criteria:

• Must be a participant from Study 104RA203 (NCT 00458861)

Exclusion Criteria:

• Participants with a significant change in medical history from their previous BG9924 Study 104RA203 (NCT 00458861).
• Nursing mothers, pregnant women, or women who are planning to become pregnant while in the study.
• Male and female participants of child-bearing potential not willing to practice effective birth control for the duration of the study.

NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.